A PCR assay amplifying a repeated sequence from the Leishmania infantum genome was compared with direct examination of bone marrow aspirate, myeloculture, and serology for the diagnosis of visceral leishmaniasis in immunocompromised patients. Of 73 patients living in an area endemic for leishmaniasis and where visceral leishmaniasis was suspected by physicians, only 10 had an indisputable diagnosis of visceral leishmaniasis. None of the diagnostic tests performed in the study achieved 100% sensitivity for diagnosing visceral leishmaniasis. PCR exhibited superior sensitivity (82%) in comparison with bone marrow aspirate examination (55%) and myeloculture (55%). Our PCR assay also showed good specificity (97%), negative predictive value (97%), and positive predictive value (82%) even when all unconfirmed PCR results were scored as false positives. Serology exhibited good sensitivity (80%v) and excellent specificity (100%), negative predictive value (98%), and positive predictive value (100%) in diagnosing new cases of visceral leishmaniasis but failed to diagnose relapses. We also observed consistent negative serological results using several different immunological detection methods for 2 of the 10 patients with confirmed cases of visceral leishmaniasis. This lack of serological reactivity persisted throughout the course of their infections. These results demonstrate the importance of using PCR as an aid in the diagnosis of visceral leishmaniasis in immunocompromised patients.
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Protozoa of the genus Leishmania are a group of morphologically similar parasites which cause a number of disease manifestations in humans, e.g., cutaneous, mucocutaneous, and visceral leishmaniasis. The major features of visceral leishmaniasis (kala azar) are intermittent fever, enlargement of the spleen, and pancytopenia. The disease leads to death if it is not treated. The agents responsible for kala azar are L. infantum, L. chagasi, and L. donovani. Visceral leishmaniasis has been reported to be an opportunistic infection in immunosuppressed patients (8) and in immunocompromised subjects such as patients with human immunodeficiency virus infection (1, 2, 10, 11, 14, 17) living in areas in which visceral leishmaniasis is endemic. Unfortunately, diagnosis of visceral leishmaniasis is difficult in such patients; serologic diagnosis is not reliable for immunosuppressed patients, direct diagnosis is not sensitive, and culture of Leishmania cells is insensitive and time-consuming. Two different approaches have been used to improve the diagnosis of visceral leishmaniasis. Mary et al. (9) proposed a means of diagnosis based on the Western blot (WB; immunoblot) technique, which is more sensitive than other serological techniques (9) . Another approach is the use of DNA-specific probes or amplification of a specific sequence of Leishmania DNA by the PCR technique. Although different authors have described PCR assays that could be useful for the diagnosis of visceral leishmaniasis (4, 12, 13, 15, 16) Table 2 ). immunocompromised (70 had human immunodeficiency virus infection with fewer than 0.2 x 109 CD4+ T cells per ml, 2 were renal transplantation recipients, and 1 had pulmonary neoplasty). The mean age of the subjects was 35 ± 7 years (range, 16 to 75 years). Patients were divided into two groups according to their histories, as follows: Group I (n = 64) included patients without a previous history of leishmaniasis and group II (n = 10) included those with a previous history of treated visceral leishmaniasis. Clinical features presented by patients in both groups were fever (n = 63), multiple adenopathies (n = 20), splenomegaly (n = 15), and hepatomegaly (n = 13). Serum abnormalities included hemoglobinemia of less than 120 g/l (n = 60), neutrophil count of less than 1.5 x 109/ml (n = 40), and platelet count of less than 1 x 10l'/ml (n = 37). BMAs were collected with a syringe containing heparin to avoid coagulation, and BMAs were transported to the laboratory at room temperature.
Immunological detection methods. The presence of L. infantum-specific antibodies was determined by four different tests: indirect immunofluorescent-antibody test (IFA), counterelectrophoresis (CEP), enzyme-linked immunosorbent assay (ELISA), and WB. IFA and CEP were performed by using L. infantum promastigotes (MCAN/FR173/LPM 56) as antigens (9) . The IFA result was regarded as positive when a 1:100 dilution of the serum gave fluorescence. CEP was performed as described by Gentilini et al. (5) by using promastigotes lysed by ultrasonic treatment; CEP was considered positive when at least one arc of precipitation formed. The preparation of L. infantum antigens from a lysate of promastigotes (MCAN/82/ GR/MON 497) and the methods used to perform ELISA and WB tests have been described previously (6, 9) . ELISA was regarded as positive when the optical density at 620 nm was more than 0.50, and WB was considered positive when sera from patients recognized either the 14-or the 16-kDa antigen.
Direct examination of BMAs. The slides were stained with Giemsa and examined with a x 10 eyepiece and a x 100 oil objective. Each sample was examined at least twice for 45 min each time by two senior parasitologists (representing more than 1,000 microscopic fields examined) before confirming or determining a negative result.
Culture of Leishmania cells. Each bone marrow sample (0.5 ml) was mixed with 3 ml of culture medium (10% fetal bovine serum [Sigma, St. Louis, Mo.] in RPMI 1640 medium [Sigma] ) that was heated for 30 min at 56°C. The mixture was then incubated for 7 days at 24°C and was examined by microscopy. When no Leishmania cells were found, 1 ml of the culture sample was subcultured onto the same medium for another 7 days at 24°C before confirming a negative result.
Preparation of Leishmania DNA for PCR amplification. A 100-,ul aliquot of BMA was added to 300 ,ul of specimen preparation buffer consisting of 20% Chelex (Bio-Rad, Paris, France), 1% Nonidet P-40 (Sigma), and 1% Tween 20 (Sigma) in distilled water. This mixture was then heated for 20 min at 96°C and was centrifuged at 13,000 x g for 10 min at room temperature. The subsequent supernatant was collected and was used immediately for PCR amplification or was stored at -20°C until use.
PCR. We used two oligonucleotide primers derived from a repetitive sequence of the L. infantum genome specific for the three agents of visceral leishmaniasis (L. infantum, L. chagasi, and L. donovani) (11) Diagnostic criteria for determining visceral leishmaniasis. The diagnosis of visceral leishmaniasis was confirmed when Leishmania cells could be visualized on direct examination or after culturing. We also considered those patients with no previous history of leishmaniasis whose sera tested positive by the four serological methods as true-positive cases even when direct examination of BMAs and myeloculture yielded negative results.
RESULTS
Of the 64 patients in group I (with no previous history of leishmaniasis), 5 had undisputed leishmaniasis. No Leishmania cells were found in BMAs from one of these patients, but all of Table 2 . Our PCR-based diagnoses exhibited superior sensitivity and negative predictive value (Table 3) than of those diagnoses determined by direct examination of BMAs (Table 4) or myeloculture (Table 5) . By our definition, direct examination and culture cannot yield false-negative results; hence, the two methods had specificities and positive predictive values of 100%. Immunological analysis was of interest for patients with no previous history of leishmaniasis (Table 6) but not for patients with relapses, because serological results for patients with a previous history of leishmaniasis typically remained positive. In patients with a previous history of leishmaniasis, only a high antibody titer signaled a relapse; the antibody titer exceeded 1/800 by IFA and 1 by ELISA for four of the six patients experiencing relapses, whereas it was less than 1/200 by IFA and less than 1 by ELISA for patients without relapses. In addition, sera from 2 of the 10 patients with confirmed cases of visceral leishmaniasis maintained consistent negative results by all four immunological detection methods.
DISCUSSION
We sought to develop a PCR-based diagnostic test for visceral leishmaniasis because none of the usual biological exams were capable of diagnosing all cases of leishmaniasis in immunocompromised hosts. We noted that the presence of specific antibodies against L. infantum were undetectable in two patients. Several investigators have already reported the absence of a serological response in immunocompromised hosts with visceral leishmaniasis (2, 7, 10), but they did not use WB analysis, which is a more sensitive technique than other serological techniques (9) . For such patients, serological analysis may lead to false-negative results. Use of immunological detection methods are also difficult for the diagnosis of relapse in patients with a previous history of visceral leishmaniasis. Indeed, these patients often preserve a positive serology that would interfere with the unambiguous detection of a relapse. Previously, the diagnosis of visceral leishmaniasis in immunocompromised hosts required direct examination of BMAs or cultivation of Leishmania cells from a BMA. As seen in the present study, even meticulous examination of BMAs can yield false-negative results because of the very low number of Leishmania cells in bone marrow or because of hemodiluted samples. Culture of Leishmania cells from BMAs may improve the direct diagnosis of visceral leishmaniasis in such patients (2) . Unfortunately, this time-consuming method can also yield false-negative results. In particular, the culture results are often negative when samples are hemodiluted or when patients are treated with pentamidine or amphotericin B for pneumocystosis or mycosis. Thus, in previous studies, establishing the diagnosis required the use of invasive techniques such as liver biopsy or splenectomy (10) . In our study, PCR confirmed the diagnosis of visceral leishmaniasis in 3 of the 10 patients. In one patient (patient 5), the diagnosis was not established because all of the tests except PCR-based diagnosis were negative, but meticulous reexamination of BMAs then confirmed it to be a true-positive result. In two other patients (patients 67 and 68), a diagnosis of relapse was suspected because antibody levels were high and results of PCR were positive, whereas results of direct examination and culture were negative. In these two patients, diagnosis was confirmed by testing another BMA. The significance of the positive PCR results associated with negative serology, myeloculture, and BMA examination was impossible to determine in two patients (patients 6 and 7) because the patients refused to undergo a second bone marrow sampling. A false-positive result because of contamination is unlikely, but it cannot be excluded.
Because our objective was to develop a fast and simple method for use in routine diagnosis, we used a sample preparation procedure that was simpler than the classical phenolchloroform extraction method. Samples for PCR can be prepared in only 1 h, and risks of sample cross-contamination are diminished. This method of specimen preparation also reduces the cost of PCR assays because all of the reagents involved are inexpensive. Even with a simplified sampling procedure, PCRbased diagnosis was more sensitive than direct examination of BMAs and myeloculture. We have previously demonstrated that our PCR assay is able to detect a single Leishmania cell without a hybridization step, because the primers we used recognize a repetitive sequence in the L. infantum genome (12) . 
